Literature DB >> 2894700

Lymphocyte beta-adrenergic receptor binding in panic disorder.

S L Brown1, D S Charney, S W Woods, G R Heninger, J Tallman.   

Abstract

Lymphocyte beta adrenergic receptor binding using [125I]CNP was determined in patients with panic disorder (N = 4) or agoraphobia with panic attacks (N = 17) and age- and sex-matched healthy subjects (N = 22). The patients showed a significantly lower number of beta-adrenergic receptor binding sites and a significantly higher affinity of binding than healthy subjects. A past or present history of major depression in the patients did not alter these findings. These results are consistent with a growing body of knowledge implicating noradrenergic dysfunction in the pathophysiology of panic anxiety.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894700     DOI: 10.1007/bf00735875

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

Review 1.  THE PSYCHOPHYSIOLOGY OF ANXIETY; WITH A REVIEW OF THE LITERATURE CONCERNING ADRENALINE.

Authors:  P R BREGGIN
Journal:  J Nerv Ment Dis       Date:  1964-12       Impact factor: 2.254

2.  Autonomic and psychic effects of yohimbine hydrochloride.

Authors:  G HOLMBERG; S GERSHON
Journal:  Psychopharmacologia       Date:  1961

3.  Beta-adrenergic receptor function in affective illness.

Authors:  G N Pandey; M W Dysken; D L Garver; J M Davis
Journal:  Am J Psychiatry       Date:  1979-05       Impact factor: 18.112

4.  The beta-adrenergic receptor in human lymphocytes: subclassification by the use of a new radio-ligand, (+/-)-125 Iodocyanopindolol.

Authors:  O E Brodde; G Engel; D Hoyer; K D Bock; F Weber
Journal:  Life Sci       Date:  1981-11-23       Impact factor: 5.037

5.  Changes in lymphocyte beta-adrenergic receptors in depression and mania.

Authors:  I Extein; J Tallman; C C Smith; F K Goodwin
Journal:  Psychiatry Res       Date:  1979-10       Impact factor: 3.222

6.  beta1- and beta2-Adrenergic receptors in rat cerebral cortex are independently regulated.

Authors:  K P Minneman; M D Dibner; B B Wolfe; P B Molinoff
Journal:  Science       Date:  1979-05-25       Impact factor: 47.728

7.  Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.

Authors:  D S Charney; G R Heninger
Journal:  Arch Gen Psychiatry       Date:  1985-05

8.  Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.

Authors:  L T Williams; R Snyderman; R J Lefkowitz
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

9.  Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.

Authors:  D S Charney; D E Redmond; M P Galloway; H D Kleber; G R Heninger; M Murberg; R H Roth
Journal:  Life Sci       Date:  1984-09-17       Impact factor: 5.037

10.  Urinary catecholamines and mitral valve prolapse in panic-anxiety patients.

Authors:  R M Nesse; O G Cameron; A J Buda; D S McCann; G C Curtis; M J Huber-Smith
Journal:  Psychiatry Res       Date:  1985-01       Impact factor: 3.222

View more
  3 in total

1.  Anxiety and cardiovascular risk: Review of Epidemiological and Clinical Evidence.

Authors:  O Olafiranye; G Jean-Louis; F Zizi; J Nunes; Mt Vincent
Journal:  Mind Brain       Date:  2011-08

2.  Beta-receptor responsiveness after desipramine treatment.

Authors:  R Pohl; G N Pandey; V K Yeragani; R Balon; J M Davis; R Berchou
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use.

Authors:  Mary J Skelly; Jeff L Weiner
Journal:  Brain Behav       Date:  2014-04-14       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.